Pediatrix Medical Group, Inc. (NYSE:MD) Receives $19.80 Average PT from Analysts

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have been assigned an average rating of “Hold” from the six analysts that are presently covering the firm, Marketbeat reports. Five equities research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $19.80.

Several research firms have recently commented on MD. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Pediatrix Medical Group in a report on Monday, December 29th. Zacks Research cut shares of Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a report on Friday, January 23rd. Deutsche Bank Aktiengesellschaft set a $19.00 price target on shares of Pediatrix Medical Group in a report on Friday, February 20th. Truist Financial cut their price target on Pediatrix Medical Group from $24.00 to $21.00 and set a “hold” rating on the stock in a research report on Thursday, February 19th. Finally, UBS Group reduced their price objective on Pediatrix Medical Group from $23.00 to $22.00 and set a “neutral” rating for the company in a research note on Tuesday, February 24th.

Insiders Place Their Bets

In other Pediatrix Medical Group news, CEO Mark S. Ordan sold 23,000 shares of the business’s stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $22.41, for a total value of $515,430.00. Following the completion of the transaction, the chief executive officer directly owned 302,805 shares of the company’s stock, valued at approximately $6,785,860.05. The trade was a 7.06% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.90% of the company’s stock.

Hedge Funds Weigh In On Pediatrix Medical Group

Several institutional investors have recently made changes to their positions in the company. Global Retirement Partners LLC boosted its holdings in Pediatrix Medical Group by 68,250.0% during the fourth quarter. Global Retirement Partners LLC now owns 1,367 shares of the company’s stock worth $29,000 after buying an additional 1,365 shares in the last quarter. Transamerica Financial Advisors LLC purchased a new position in Pediatrix Medical Group in the fourth quarter valued at $30,000. Eurizon Capital SGR S.p.A. acquired a new position in shares of Pediatrix Medical Group in the fourth quarter worth about $33,000. Blue Trust Inc. acquired a new position in shares of Pediatrix Medical Group in the fourth quarter worth about $37,000. Finally, TD Private Client Wealth LLC purchased a new stake in shares of Pediatrix Medical Group during the 4th quarter worth about $39,000. 97.71% of the stock is owned by hedge funds and other institutional investors.

Pediatrix Medical Group Trading Up 0.3%

Shares of NYSE:MD opened at $19.79 on Monday. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.66. Pediatrix Medical Group has a 52-week low of $11.84 and a 52-week high of $24.99. The stock has a market cap of $1.64 billion, a price-to-earnings ratio of 10.20 and a beta of 0.79. The business has a 50-day moving average price of $21.01 and a 200-day moving average price of $20.00.

Pediatrix Medical Group (NYSE:MD) last issued its earnings results on Thursday, February 19th. The company reported $0.50 EPS for the quarter, missing analysts’ consensus estimates of $0.53 by ($0.03). Pediatrix Medical Group had a net margin of 8.64% and a return on equity of 19.59%. The firm had revenue of $493.77 million during the quarter, compared to analysts’ expectations of $486.23 million. During the same quarter in the prior year, the company earned $0.51 EPS. Pediatrix Medical Group’s quarterly revenue was down 1.7% on a year-over-year basis. Equities analysts predict that Pediatrix Medical Group will post 1.38 EPS for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.